Myocardial perfusion imaging with adenosine triphosphate predicts the rate of cardiovascular events

Journal of Nuclear Cardiology

Volumn 13, Issue 3, 2006, Pages 316-323

  Coma Canella, Isabel ^a   Palazuelos, Jorge ^a   Bravo, Nieves ^a   García Velloso, María José ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

adenosine triphosphate; ischemia; myocardial perfusion imaging; Pharmacologic stress; single photon emission computed tomography

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINOPHYLLINE; THALLIUM 201;

ADULT; AGE; AGED; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION FUNCTION; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE SEVERITY; DIZZINESS; DYSPNEA; FEMALE; FLUSHING; FOLLOW UP; HEADACHE; HEART MUSCLE PERFUSION; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REST; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THORAX PAIN; TREMOR;

ADENOSINE; ADENOSINE TRIPHOSPHATE; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PERFUSION; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33646948022     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.02.010     Document Type: Article

References (30)

1. Beller G.A. First annual Mario S. Verani, MD, memorial lecture. clinical value of myocardial perfusion imaging in coronary artery disease. J Nucl Cardiol 10 (2003) 529-542
2. Iskandrian A.S., Heo J., Lemlek J., Ogilby J.D., Untereker W.J., Iskandrian B., et al. Identification of high-risk patients with left main and three-vessel coronary artery disease by adenosine-single photon emission computed tomographic thallium imaging. Am Heart J 125 (1993) 1130-1135
3. Taillefer R., Amyot R., Turpin S., Lambert R., Pilon C., and Jarry M. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging. J Nucl Cardiol 3 (1996) 204-211
4. Belhassen B., and Pelleg A. Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart. clinical and experimental aspects. J Am Coll Cardiol 4 (1984) 414-424
5. Ballo P., Bernabo D., and Faraguti S.A. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. Eur Heart J 25 (2004) 1277-1278
6. Watanabe K., Sekiya M., Ikeda S., Miyagawa M., Kinoshita M., and Kumano S. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med 38 (1997) 577-581
7. Miyagawa M., Kumano S., Sekiya M., Watanabe K., Akutzu H., Imachi T., et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. J Am Coll Cardiol 26 (1995) 1196-1201
8. Shoyeb A., Bokhari S., Sullivan J., Hurley E., Miesner B., Pia R., et al. Value of definitive diagnostic testing in the evaluation of patients presenting to the emergency department with chest pain. Am J Cardiol 91 (2003) 1410-1414
9. Bravo N., Giménez M., Mejía S., García-Velloso M.J., and Coma-Canella I. Prognostic value of myocardial perfusion imaging with adenosine triphosphate. J Nucl Cardiol 9 (2002) 395-401
10. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report. JAMA 289 (2003) 2560-2571
11. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 25 Suppl 1 (2002) S33-S49
12. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 21 (2000) 1502-1513
13. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation 105 (2002) 539-542
14. Anagnostopoulos C., Harbinson M., Kelion A., Kundley K., Loong C.Y., Notghi A., et al. Procedure guidelines for radionuclide myocardial perfusion imaging. Heart 90 Suppl 1 (2004) i1-i10
15. Kurata C., Tawarahara K., Taguchi T., Sakata K., Yamazaki N., and Naitoh Y. Lung thallium-201 uptake during exercise emission computer tomography. J Nucl Med 32 (1991) 417-423
16. Westfall P.H., and Wolfinger R.D. Multiple tests with discrete distributions. Am Stat 51 (1997) 3-8
17. Cleland O.S., Kjekshus R.M., and Dickstein D. Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction. Am J Med 118 (2005) 752-758
18. Amanullah A.M. Diagnostic and prognostic value of myocardial perfusion imaging in patients with known or suspected stable coronary artery disease. Echocardiography 17 (2000) 587-595
19. Beller G.A., and Zaret B.L. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 101 (2000) 1465-1478
20. Shaw L., Miller D.D., Kong B.A., Hilton T., Stelken A., Stocke K., et al. Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging. Am Heart J 124 (1992) 861-869
21. Sanders G.P., Pinto D.S., Parker J.A., Koutkia P., Aepfelbacher F.C., and Danias P.G. Increased resting Tl-201 lung-to-heart ratio is associated with invasively determined measures of left ventricular dysfunction, extent of coronary artery disease, and resting myocardial perfusion abnormalities. J Nucl Cardiol 10 (2003) 140-147
22. Kaminek M., Myslivecek M., Skvarilova M., Husak V., Koranda P., Metelkova I., et al. Increased prognostic value of combined myocardial perfusion SPECT imaging and the quantification of lung Tl-201 uptake. Clin Nucl Med 27 (2002) 255-260
23. Nishimura S., Mahmarian J.J., and Verani M.S. Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy. J Nucl Med 33 (1992) 1600-1607
24. Maceira A.M., Cabrera A., Albaladejo V.J., Garcia Velloso M.J., Richter J.A., and Coma-Canella I. Thallium-201 uptake in lung and heart with different types of stress. Study in healthy volunteers. [in Spanish]. Rev Esp Med Nucl 18 (1999) 197-203
25. Shaw L.J., and Iskandrian A.E. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11 (2004) 171-185
26. Calnon D.A., McGrath P.D., Doss A.L., Harrell F.E., Watson D.D., and Beller G.A. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging. stratification of a high-risk population. J Am Coll Cardiol 38 (2001) 1511-1517
27. Yonezawa Y., Yoshikawa J., Shakudo M., Okumachi F., Shiratori K., Koizumi K., et al. Adenosine triphosphate loading thallium-201 myocardial scintigraphy. optimal dose and diagnostic accuracy. [in Japanese]. J Cardiol 25 (1995) 9-13
28. He Q., Yao Z., Yu X., Qu W., Sun F., Ji F., et al. Evaluation of (99m)Tc-MIBI myocardial perfusion imaging with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. Chin Med J (Engl) 115 (2002) 1603-1607
29. Miyazono Y., Kisanuki A., Toyonaga K., Matsushita R., Otsuji Y., Arima S., et al. Usefulness of adenosine triphosphate-atropine stress echocardiography for detecting coronary artery stenosis. Am J Cardiol 82 (1998) 290-294
30. Cerqueira M.D., Verani M.S., Schwaiger M., Heo J., and Iskandrian A.S. Safety profile of adenosine stress perfusion imaging. results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 23 (1994) 384-389